News

  • 14 March 2019

    Neurotrope doses last patient in Alzheimer’s trial

    Neurotrope has completed enrolment and initiated dosing in the last patient of a Phase II clinical trial evaluating Bryostatin-1 for the treatment of moderate to severe Alzheimer’s disease.

  • 13 March 2019

    Lilly’s Cyramza clears Phase III lung cancer trial

    Eli Lilly has reported positive results from the Phase III RELAY clinical trial performed to evaluate Cyramza (ramucirumab) in metastatic non-small cell lung cancer (NSCLC) patients with activating EGFR mutations.

  • 12 March 2019

    Janssen’s UNIFI trial of Stelara meets primary endpoint

    Janssen Pharmaceutical has reported positive results from the Phase III UNIFI clinical trial of subcutaneous (SC) Stelara (ustekinumab) as a maintenance therapy in adults with moderate to severe ulcerative colitis...

  • 11 March 2019

    Takeda reports positive Phase IIIb results for vedolizumab

    Takeda Pharmaceutical has reported positive results from the Phase IIIb head-to-head VARSITY clinical trial of gut-selective biologic vedolizumab (Entyvio) for the treatment of moderately to severely active ulcerative colitis (UC).

Go Top